Full Press Release Details
dupixent dupilumab late breaking data from notus confirmatory phase 3 copd trial presented at ats and published in the new england journal of medicine.
REGN
dupixent dupilumab late breaking data from notus confirmatory phase 3 copd trial presented at ats and published in the new england journal of medicine
Key Takeaway: dupixent dupilumab late breaking data from notus confirmatory phase 3 copd trial presented at ats and published in the new england journal of medicine